Logo Logo
Hilfe
Hilfe
Switch Language to English

Greiffo, Flavia R.; Eickelberg, Oliver und Fernandez, Isis E. (2017): Systems medicine advances in interstitial lung disease. In: European Respiratory Review, Bd. 26, Nr. 145, 170021

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Fibrotic lung diseases involve subject-environment interactions, together with dysregulated homeostatic processes, impaired DNA repair and distorted immune functions. Systems medicine-based approaches are used to analyse diseases in a holistic manner, by integrating systems biology platforms along with clinical parameters, for the purpose of understanding disease origin, progression, exacerbation and remission. Interstitial lung diseases (ILDs) refer to a heterogeneous group of complex fibrotic diseases. The increase of systems medicine-based approaches in the understanding of ILDs provides exceptional advantages by improving diagnostics, unravelling phenotypical differences, and stratifying patient populations by predictable outcomes and personalised treatments. This review discusses the state-of-the-art contributions of systems medicine-based approaches in ILDs over the past 5 years.

Dokument bearbeiten Dokument bearbeiten